(19)
(11) EP 1 835 948 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
06.04.2016 Bulletin 2016/14

(45) Mention of the grant of the patent:
24.02.2016 Bulletin 2016/08

(21) Application number: 05818406.0

(22) Date of filing: 20.12.2005
(51) International Patent Classification (IPC): 
A61L 27/24(2006.01)
A61F 2/24(2006.01)
A61L 27/58(2006.01)
 A61F 2/02(2006.01)
A61L 27/38(2006.01)
(86) International application number:
PCT/AU2005/001928
(87) International publication number:
WO 2006/066327 (29.06.2006 Gazette 2006/26)

(54)

AN IMPLANTABLE BIOMATERIAL AND A METHOD OF PRODUCING SAME

IMPLANTIERBARES BIOLOGISCHES MATERIAL UND HERSTELLUNGSVERFAHREN

BIOMATERIAU IMPLANTABLE ET SON PROCEDE DE PRODUCTION

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated Extension States:
AL BA HR MK YU

(30) Priority: 24.12.2004 AU 2004907348

(43) Date of publication of application:
26.09.2007 Bulletin 2007/39

(73) Proprietor: Admedus Regen Pty Ltd.
Malaga WA 6090 (AU)

(72) Inventors:
  • NEETHLING, William Morris Leonard
    Booragoon, W.A. 6154 (AU)
  • HODGE, Andrew Julian
    Winthrop, W.A. 6150 (AU)

(74) Representative: Minoja, Fabrizio et al
Bianchetti Bracco Minoja S.r.l. Via Plinio, 63
20129 Milano
20129 Milano (IT)


(56) References cited: : 
WO-A1-84/01894
US-A- 5 746 775
 US-A- 5 746 775
   
  • VYAVAHARE N ET AL: "Prevention of bioprosthetic heart valve calcifiation by ethanol preincubation: Efficacy and Mechanisms", CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, US, vol. 95, 1 January 1997 (1997-01-01), pages 479-488, XP008134160, ISSN: 0009-7322
  • PATHAK C. ET AL.: 'Treatment of bioprosthetic heart valve tissue with long chain alcohol solution to lower calcification potential' BIOMED. MATER. RES. A. vol. 69, no. 1, April 2004, pages 140 - 144, XP008122637
  • VYAVAHARE N. ET AL.: 'Prevention of bioprosthetic heart valve calcifiation by ethanol preincubation: Efficacy and Mechanisms' CIRCULATION vol. 95, 1997, pages 479 - 488, XP008134160
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).